Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Late annual account NBB
Fiscal year 2023 was filed 482 days after the legal deadline.
-
Annual account missing NBB
Fiscal year 2024 was expected before 31 July 2025 and has not been filed.
Financials
Financial year 2023
CONMED Europe from Drogenbos, company number BE0463420369, closed financial year 2023 with a result of € 2.9 million after tax. For that financial year CONMED Europe recorded revenue of € 36.9 million and equity of € 124.5 million. Compared with financial year 2022, the result moved from € -15.2 million to € 2.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 25, 2025.
€ 124.5 million
▲ 2% vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2.9 million
▲ still € 15.2 million loss in 2022
Profit after tax over the fiscal year.
€ 804,767
▲ 24% vs 2022
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2023. Retained profit grew to € -44.9 million.
People and assets in 2023
47.7
▼ 6.3 vs 2022
Average over the fiscal year, from the social balance sheet.
€ 5.2 million
▲ 1% vs 2022
€ 108,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 400,161
▲ 6% vs 2022
Book value of vehicles, furniture and equipment.
Debts at end 2023
€ 3.8 million
Loans from banks and other lenders, long and short.
€ 1.5 million
▲ 37% vs 2022
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 20 days on average.
€ 1.6 million
▼ 3% vs 2022
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | Change 2022 → 2023 | |
|---|---|---|---|---|
| Revenue | € 21,482,527 | € 25,558,194 | € 36,914,723 | ▲ 44% |
| Profit after taxes | € 509,666 | € -15,150,149 | € 2,943,343 | ▲ € 18.1 million |
| Equity | € 136,687,529 | € 121,537,381 | € 124,480,724 | ▲ 2% |
| Total debts | € 7,601,532 | € 6,537,453 | € 7,847,760 | ▲ 20% |
| Cash | € 498,674 | € 649,518 | € 804,767 | ▲ 24% |
| Retained profit | € -32,657,165 | € -47,807,314 | € -44,863,971 | ▲ € 2.9 million |
| Bank debt | € 0 | € 0 | € 3,800,000 | |
| Balance sheet total | € 144,300,733 | € 128,083,570 | € 132,339,385 | ▲ 3% |
| Employees (FTE) | 53.8 | 54 | 47.7 | ▼ 6.3 |
Key figures of CONMED Europe, fiscal years 2021 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.
What happened to CONMED Europe?
What happened at CONMED Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2023: profit of € 2.9 million. filed late Source: NBB ↗
- Stephan Epinette became a director. NBB
- Sven Van Kets became a director. NBB
- Patrick Beyer stepped down as director. NBB
- Heather L. Cohen stepped down as director. NBB
- Heather L. Cohen became a director. NBB
- Johonna Pelletier became a director. NBB
- Patrick Beyer became a director. NBB
In short
From € 509,666 profit in 2021 to € 2.9 million profit in 2023.
Paid € 356,075 in corporate taxes since 2021.
Best year ever: 2023, with € 2.9 million profit.
Pays suppliers within 20 days on average.
A new publication or filing at CONMED Europe? We notify you, reason included.
Follow CONMED EuropeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind CONMED Europe are Johonna Pelletier, Stephan Epinette and Sven Van Kets. The shares are held by Linvatec Belgium (100%). It owns 100% of LINVATEC AUSTRIA GMBH, 100% of CONMED DEUTSCHLAND GMBH, 100% of CONMED LINVATEC BIOMATERIALS OY, 100% of LINVATEC POLSKA SP. ZOO, 100% of LINVATEC DENMARK APS and 100% of CONMED FRANCE SAS itself.
Directors
According to the 2023 annual accounts
since 2018
since 2025
since 2025
Patrick Beyer
Director
since 2015 · until 2025
since 2023 · until 2024
Shareholders
100%
Participations
LINVATEC AUSTRIA GMBH
100%
CONMED DEUTSCHLAND GMBH
100%
CONMED LINVATEC BIOMATERIALS OY
100%
LINVATEC POLSKA SP. ZOO
100%
LINVATEC DENMARK APS
100%
CONMED FRANCE SAS
100%
CONMED UK LTD
100%
CONMED LINVATEC AUSTRALIA PTY LTD
100%
Establishments
Establishment units
Physical locations of this company
W.A. Mozartlaan 3
1620 Drogenbos
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
MICROSOFT-CORP-MSN-AS-BLOCK - Microsoft Corporation, US
Domain
Domain
conmed.com
Registered
1995-10-12
Registrar
Network Solutions, LLC
Expires
2030-10-11
Website info
Features
Security
Details
- Company number
- 0463.420.369
- VAT number
- BE 0463.420.369
- Registered office
- W.A. Mozartlaan 3, 1620 Drogenbos
- Names & denominations
- CONMED Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 May 1998
- Peppol
- Active · Active since 3 Dec 2025
- Contact
- conmed.com
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Coördinatiecentra
Activiteiten van hoofdkantoren